Trusted by over 1.1 million users
Conclusion: Making Informed Decisions About Semaglutide Therapy Semaglutides side effect profile is well-characterized through extensive clinical trial data involving over 11,000 participants in the SUSTAIN and PIONEER programs, thousands more in the STEP weight management trials, and ongoing real-world surveillance
Chiappini S, Vickers-Smith R, Harris D, Papanti Pelletier GD, Corkery JM, Guirguis A, et al
We use very fine needles and a gentle technique to ensure your comfort throughout the brief procedure
Participants were randomly assigned, 1:1:1, to once-weekly combination cagrilintide and semaglutide 2.4 mg, once-weekly semaglutide 2.4 mg plus placebo or once-weekly cagrilintide 2.4 mg plus placebo